Aydin Huseynov is an analyst at Ladenburg Thalmann. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/16/2024
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 05/14/2024 | CAPR | Buy Now | Capricor Therapeutics | $5.80 | 331.03% | $24 → $25 | Maintains | Buy | Get Alert |
| 04/30/2024 | MRKR | Buy Now | Marker Therapeutics | $4.25 | 158.82% | → $11 | Initiates | → Buy | Get Alert |
| 04/29/2024 | ACRV | Buy Now | Acrivon Therapeutics | $8.56 | — | — | Downgrade | Buy → Neutral | Get Alert |
| 04/18/2024 | ALRN | Buy Now | Aileron Therapeutics | $3.84 | 394.79% | $9 → $19 | Maintains | Buy | Get Alert |
| 04/05/2024 | ACRV | Buy Now | Acrivon Therapeutics | $8.56 | 63.55% | $18 → $14 | Maintains | Buy | Get Alert |
| 03/14/2024 | SPRB | Buy Now | Spruce Biosciences | $0.76 | — | — | Downgrade | Buy → Neutral | Get Alert |
| 02/08/2024 | BDRX | Buy Now | Biodexa Pharmaceuticals | $1.31 | 510.69% | → $8 | Initiates | → Buy | Get Alert |
| 12/27/2023 | PMVP | Buy Now | PMV Pharma | $2.17 | 222.58% | → $7 | Initiates | → Buy | Get Alert |
| 12/01/2023 | ALRN | Buy Now | Aileron Therapeutics | $3.84 | 134.38% | → $9 | Upgrade | Neutral → Buy | Get Alert |
| 10/10/2023 | ZURA | Buy Now | Zura Bio | $6.00 | 66.67% | → $10 | Initiates | → Buy | Get Alert |
| 09/22/2023 | COEP | Buy Now | Coeptis Therapeutics | $0.33 | 799.55% | → $3 | Initiates | → Buy | Get Alert |
| 08/14/2023 | CGTX | Buy Now | Cognition Therapeutics | $1.97 | 204.57% | $10 → $6 | Maintains | Buy | Get Alert |
| 06/05/2023 | ATHE | Buy Now | Alterity Therapeutics | $1.95 | 412.82% | $20 → $10 | Maintains | Buy | Get Alert |
| 05/30/2023 | CRVS | Buy Now | Corvus Pharma | $2.34 | 327.35% | $4 → $10 | Maintains | Buy | Get Alert |
| 05/16/2023 | PALI | Buy Now | Palisade Bio | $6.04 | 164.9% | $375 → $240 | Maintains | Buy | Get Alert |
| 04/28/2023 | TPST | Buy Now | Tempest Therapeutics | $3.24 | 332.1% | $8 → $14 | Maintains | Buy | Get Alert |
| 04/04/2023 | PCSA | Buy Now | Processa Pharma | $2.01 | 99% | $180 → $80 | Maintains | Speculative Buy | Get Alert |
| 03/07/2023 | ADVM | Buy Now | Adverum Biotechnologies | $8.25 | -75.76% | → $20 | Initiates | → Buy | Get Alert |
| 12/07/2022 | NRBO | Buy Now | NeuroBo Pharmaceuticals | $4.45 | 34.83% | → $48 | Initiates | → Buy | Get Alert |
| 11/15/2022 | CALA | Buy Now | Calithera Biosciences | $0.03 | — | — | Downgrade | Buy → Neutral | Get Alert |
| 11/04/2022 | NXTC | Buy Now | NextCure | $1.65 | — | — | Downgrade | Buy → Neutral | Get Alert |
| 10/26/2022 | CAPR | Buy Now | Capricor Therapeutics | $5.80 | 158.62% | → $15 | Initiates | → Buy | Get Alert |
| 10/07/2022 | CRVS | Buy Now | Corvus Pharma | $2.34 | -14.53% | → $2 | Initiates | → Buy | Get Alert |
| 09/15/2022 | TPST | Buy Now | Tempest Therapeutics | $3.24 | 146.91% | → $8 | Initiates | → Buy | Get Alert |
| 08/31/2022 | STSA | Buy Now | Satsuma Pharma | — | — | → $16 | Initiates | → Buy | Get Alert |
| 08/23/2022 | ALLR | Buy Now | Allarity Therapeutics | $0.69 | — | — | Downgrade | Buy → Neutral | Get Alert |
| 08/03/2022 | ATHE | Buy Now | Alterity Therapeutics | $1.95 | 2.56% | → $20 | Initiates | → Buy | Get Alert |
| 07/27/2022 | ANEB | Buy Now | Anebulo Pharmaceuticals | $2.80 | 114.29% | → $6 | Initiates | → Buy | Get Alert |
| 07/13/2022 | NVCT | Buy Now | Nuvectis Pharma | $6.65 | 215.79% | → $21 | Initiates | → Buy | Get Alert |
| 05/27/2022 | ALLR | Buy Now | Allarity Therapeutics | $0.69 | 1066.35% | → $224000 | Initiates | → Buy | Get Alert |
